This Pune startup had developed a facemask that inactivates novel COVID-19

Pune-based startup Thincr Technologies India Pvt Ltd has integrated 3D printing and pharmaceuticals to develop a mask, which inactivates viral particles that come in contact with it, the Department of Science and Technology said on Monday.

According to the startup, these masks are coated with anti-viral agents, otherwise known as virucides.

The coating has been tested and shown to inactivate the SARS-CoV-2, the DST said, adding the material used in it is a soap-forming agent called Sodium Olefin Sulfonate-based mixture.

When in contact with enveloped viruses, it disrupts the outer membrane of the virus. The ingredients used are stable at room temperature and are widely used in cosmetics.

The DST said that as part of the fight against COVID-19, the virucidal mask initiative was among the earliest projects to have been selected for commercialisation by the Technology Development Board (TDB), a statutory body under the Department of Science and Technology.

ALSO READ

How the ONGC Foundation is helping states make the COVID-19 vaccination drive a success

Thincr Technologies India is developing Fused Deposition Modeling (FDM) 3D-printers to discover new pharmaceutical formulations and drug-loaded filaments of different types.

"We sensed that use of face masks will become nearly universal as the most important tool to prevent infection. But we realised that most masks, which were then available and within the reach of common people, were homemade and of relatively low quality.

"It is this need for high-quality masks which led us to undertake a project to develop and commercialise cost-effective and more efficient virucidal coated masks as a better approach to reduce the spread of infection," said Shitalkumar Zambad, Founder-Director, Thincr Technologies India.

Thincr Technologies India has applied for a patent for this product. Its commercial-scale manufacturing has also started, he added.